Arintra vs Idexx Laboratories
Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $21M Series A (Aug 2025) led by Peak XV Partners with Endeavor Health Ventures and YC. Coding Copilot enables 90% faster chart coding. 5%+ revenue uplift, 43%+ fewer denials.
About
Arintra is an AI medical coding platform that autonomously codes clinical charts with no human intervention, delivering measurable improvements in coding accuracy and speed. The company raised $21 million in Series A financing in August 2025 led by Peak XV Partners (formerly Sequoia India/SEA), with Endeavor Health Ventures and Y Combinator as co-investors. The Coding Copilot enables medical coders to work 90% faster by surfacing recommended codes with supporting clinical documentation.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
About
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.